Novo Nordisk blockbuster Ozempic boasts 23% sales surge in 2023
Pharmaceutical Technology
APRIL 28, 2023
In 2022, US sales of Ozempic contributed to 65% of global sales; this is expected to continue, with the US market forecast to continue capturing the majority of sales, generating $71bn between 2023–2029. It is forecast that Ozempic will sustain its sales growth over the next five years, with an expected annual sales figure of $17bn in 2029.
Let's personalize your content